GSK plc ADR buy The Goldman Sachs Group, Inc.
Start price
27.02.23
/
50%
€33.00
Target price
27.02.24
-
Performance (%)
18.79%
End price
28.02.24
€39.20
Summary
This prediction ended on 28.02.24 with a price of €39.20. The BUY prediction by The_Goldman_Sachs_Gr finished with a performance of 18.79%. A total of €1.34 was paid as dividends for this prediction. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| GSK plc ADR | 4.651% | 4.651% | 30.058% | 41.509% |
| iShares Core DAX® | -1.283% | 4.209% | 7.084% | 64.252% |
| iShares Nasdaq 100 | -3.338% | -1.744% | 26.177% | 84.969% |
| iShares Nikkei 225® | -4.286% | -1.621% | 44.320% | 79.253% |
| iShares S&P 500 | -2.311% | -0.096% | 20.823% | 68.079% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten